Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

Clinical trial NCT03486561 · UNKNOWN

Trial details

NCT number: NCT03486561
Sponsor: OBS Pakistan
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Stable Angina

Start date: 2018-04-01
Primary completion: 2018-09-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.